Research Overview

Snakebite affects millions of people every year and is estimated to cause >100,000 deaths and 400,000 life-altering injuries annually. Conventional antivenoms are the current mainstay treatment but are associated with many issues including high cost, poor stability, being snake species-specific, the need to be delivered intravenously, and poor efficacy against local tissue necrosis caused by cytotoxic snake venoms. Dr Hall’s research is therefore focused on (i) the pharmacological determination of synergistic drug combinations with multi-species efficacy, and (ii) the development of local drug administration methods that could be exploited to better treat the devastating effects of snakebite-induced tissue necrosis.